Say something
The Bangalore-based firm has finally received some recognition with the World Economic Forum (WEF) choosing it as one of the 39 technology pioneers from a list of 273 nominees. Neurosynaptics, the only company from India in a list dominated by 23 US firms, has been picked for its ReMeDi (Remote Medical Diagnostics) range of products.
Making appointments with doctors instantly online without any hassle is just one of the features that a recently launched web portal www.doctoratclick.com is promising users.
Fortis Healthcare is considered to have one of the best IT infrastructure among healthcare providers in India and is proud of being the pioneer in deploying Web-based HIS system.
Information and communication technologies (ICT) have been recognised in the past decades as an essential tool for the scientific, economic and social development of a country.
An application by AIIMS is being processed by the ministry of civil aviation and permission has been sought to construct a helipad. The service will be available at the AIIMS trauma centre which has been operational for the past 10 months.
US-based $23-billion diversified technology firm 3M is in talks with top domestic pharma companies to licence drug delivery technologies.
ICICI Venture is planning to float a company that will buy medium-sized hospitals and pharmacy chains and act as a holding company for the fund
ICICI Venture is planning to float a company that will buy medium-sized hospitals and pharmacy chains and act as a holding company for the fund
Pfizer, a US-based pharmaceutical giant, is looking to cut costs by outsourcing as much as 30 per cent of its manufacturing to facilities in Asia, particularly in India and China.
The pharma sector may have underperformed in the Sensex , but companies providing contract research and manufacturing services (CRAMS) to global pharma companies have given good returns.
IBM is targeting multi-billion dollar health business opportunities in India. The company has plans to tap opportunities worth $1 billion each in the Indian pharmaceuticals and health service segments over the next 3-4 years.
India is considering a proposal to hike costs of obtaining blood via tranfusion by up to 70% as part of a plan to revise service charges to help pay for more advanced testing and storage of blood.
IBM is targeting multi-billion dollar health business opportunities in India. The company has plans to tap opportunities worth $1 billion each in the Indian pharmaceuticals and health service segments over the next 3-4 years.
